Floatz logo

Fasinumab

Abdominal Pain Upper

Regeneron Pharmaceuticalsmonoclonal_antibodyPhase 2Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Abdominal Pain Upper cohort.

Asset / SponsorPhaseRating
da-9701
Seoul National University Hospital
Phase 4BB
TANNIC ACID
Hospital Infantil Cândido Fontoura
Phase 3BB
LIDOCAINE
Hospital Infantil Cândido Fontoura
Phase 3BB
N-(P-(2-(DIMETHYLAMINO)ETHOXY)BENZYL)VERATRAMIDE
Abbott
Phase 3BB

Same molecule, other indications

Fasinumab is also rated in:

Low Back PainDormant
CCC
Indicative ·
48 / 100
View asset →
osteoarthritisDormant
CC
Indicative ·
47 / 100
View asset →
sciaticaDormant
CC
Indicative ·
45 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →